These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Encapsulation of Amikacin into Microparticles Based on Low-Molecular-Weight Poly(lactic acid) and Poly(lactic acid- Glinka M; Filatova K; Kucińska-Lipka J; Bergerova ED; Wasik A; Sedlařík V Mol Pharm; 2021 Aug; 18(8):2986-2996. PubMed ID: 34196555 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route. Lalla JK; Sapna K J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. Jalil R; Nixon JR J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting the size and uniformity of hollow poly(lactic acid) microcapsules fabricated from microbubble templates. Cornejo JJ; Daiguji H; Takemura F J Phys Chem B; 2011 Dec; 115(47):13828-34. PubMed ID: 22014126 [TBL] [Abstract][Full Text] [Related]
10. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone. Jalil R; Nixon JR J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. Park SJ; Kim SH J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of poly(vinyl alcohol) mediated prevention of aggregation and stabilization of insulin in nanoparticles. Rawat S; Gupta P; Kumar A; Garg P; Suri CR; Sahoo DK Mol Pharm; 2015 Apr; 12(4):1018-30. PubMed ID: 25644480 [TBL] [Abstract][Full Text] [Related]
13. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation. Vidmar V; Smolcić-Bubalo A; Jalsenjak I J Microencapsul; 1984; 1(2):131-6. PubMed ID: 6336522 [TBL] [Abstract][Full Text] [Related]
14. Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid). Andreopoulos AG J Biomater Appl; 1995 Oct; 10(2):163-70. PubMed ID: 8618209 [TBL] [Abstract][Full Text] [Related]
15. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization. Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839 [TBL] [Abstract][Full Text] [Related]
16. Microencapsulation of maltogenic α-amylase in poly(urethane-urea) shell: inverse emulsion method. Maciulyte S; Kochane T; Budriene S J Microencapsul; 2015; 32(6):547-58. PubMed ID: 26190216 [TBL] [Abstract][Full Text] [Related]